These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20113940)
1. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940 [TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials. Singla NK; Foster KN; Alexander WA; Pribble JP Pharmacotherapy; 2012 Nov; 32(11):998-1005. PubMed ID: 23108631 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis. Singla NK; Gasparis AP; Ballard JL; Baron JM; Butine MD; Pribble JP; Alexander WA; J Am Coll Surg; 2011 Dec; 213(6):722-7. PubMed ID: 21958507 [TBL] [Abstract][Full Text] [Related]
4. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis. Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision. Foster KN; Mullins RF; Greenhalgh DG; Gamelli RL; Glat P; Lentz CW; Kahn SA; Brandigi C; Fredlund P; Alexander WA J Pediatr Surg; 2011 Oct; 46(10):1992-9. PubMed ID: 22008340 [TBL] [Abstract][Full Text] [Related]
6. Recombinant thrombin: safety and immunogenicity in burn wound excision and grafting. Greenhalgh DG; Gamelli RL; Collins J; Sood R; Mozingo DW; Gray TE; Alexander WA J Burn Care Res; 2009; 30(3):371-9. PubMed ID: 19349898 [TBL] [Abstract][Full Text] [Related]
7. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures. Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA; J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754 [TBL] [Abstract][Full Text] [Related]
8. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins. Ofosu FA; Crean S; Reynolds MW Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142 [TBL] [Abstract][Full Text] [Related]
9. Persistence of antibodies to the topical hemostat bovine thrombin. Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172 [TBL] [Abstract][Full Text] [Related]
10. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072 [TBL] [Abstract][Full Text] [Related]
11. A review of three stand-alone topical thrombins for surgical hemostasis. Cheng CM; Meyer-Massetti C; Kayser SR Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705 [TBL] [Abstract][Full Text] [Related]
12. Topical recombinant human thrombin in surgical hemostasis. Bowman LJ; Anderson CD; Chapman WC Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of a dry-powder, fibrin sealant in vascular procedures. Gupta N; Chetter I; Hayes P; O-Yurvati AH; Moneta GL; Shenoy S; Pribble JP; Zuckerman LA J Vasc Surg; 2015 Nov; 62(5):1288-95. PubMed ID: 26254451 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a novel, dry powder fibrin sealant for hemostasis in hepatic resection. Ruitenbeek K; Ayez N; Verhoef C; de Wilt JH; Bottema J; Rijken AM; van Rij M; Koopman J; Zuckerman LA; Frohna P; Porte RJ Dig Surg; 2014; 31(6):422-7. PubMed ID: 25592001 [TBL] [Abstract][Full Text] [Related]
15. Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis. Vannorsdall MD; Arkel YS; Ku DH; Lucas FL; Himmelfarb J Kidney Int; 2003 Aug; 64(2):690-6. PubMed ID: 12846767 [TBL] [Abstract][Full Text] [Related]
16. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature. Rodgers GM J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719 [TBL] [Abstract][Full Text] [Related]
17. Preclinical safety of recombinant human thrombin. Heffernan JK; Ponce RA; Zuckerman LA; Volpone JP; Visich J; Giste EE; Jenkins N; Boster D; Pederson S; Knitter G; Palmer T; Wills M; Early RJ; Rogge MC Regul Toxicol Pharmacol; 2007 Feb; 47(1):48-58. PubMed ID: 16971028 [TBL] [Abstract][Full Text] [Related]
19. Prospective, Randomized, Phase II, Non-Inferiority Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgery. Minkowitz H; Navarro-Puerto J; Lakshman S; Singla S; Cousar C; Kim R; Villavicencio A; Kirksey L; Ayguasanosa J; J Am Coll Surg; 2019 Nov; 229(5):497-507.e1. PubMed ID: 31376435 [TBL] [Abstract][Full Text] [Related]
20. Topical bovine thrombin and adverse events: a review of the literature. Clark J; Crean S; Reynolds MW Curr Med Res Opin; 2008 Jul; 24(7):2071-87. PubMed ID: 18549663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]